A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study-Reference-Cited by-同舟云学术

A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study

Published:2023-02 Issue:2 Volume:78 Page:312-321
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Fagan Andrew^ORCID,Gavis Edith A.^ORCID,Gallagher Mary Leslie,Mousel Travis,Davis Brian,Puri Puneet,Sterling Richard K.^ORCID,Luketic Velimir A.^ORCID,Lee Hannah,Matherly Scott C.,Sanyal Arun J.,Stravitz R. Todd,Patel Vaishali,Siddiqui Mohammad S.,Asgharpour Amon,Fuchs Michael,Thacker Leroy^ORCID,Bajaj Jasmohan S.^ORCID

Funder

U.S. Department of Veterans Affairs

Agios Pharmaceuticals

Instituto Grifols

Publisher

Elsevier BV

Subject

Hepatology

Reference36 articles.

1. Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy;Bajaj;Hepatology,2009

2. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American association for the study of liver diseases and the European association for the study of the liver;Vilstrup;Hepatology,2014

3. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy;Bajaj;Gastroenterology,2010